Does Physical Exercise Ameliorate Chronic Kidney Disease-Related Complications? The Case of Anaemia and Chronic Kidney Disease-Mineral Bone Disorder

被引:0
作者
Aucella, Filippo [1 ]
Amicone, Maria [2 ]
Ys, Aurora del Mar Perez [1 ]
Aucella, Francesco [1 ]
Gatta, Giuseppe [1 ]
Prencipe, Michele Antonio [1 ]
Riccio, Eleonora [2 ]
Capuano, Ivana [2 ]
Pisani, Antonio [2 ]
Battaglia, Yuri [3 ]
机构
[1] Res Hosp Casa Sollievo Sofferenza Fdn, Dept Med Sci, Nephrol & Dialysis Unit, San Giovanni Rotondo, Italy
[2] Feder II Univ, Dept Publ Hlth, Naples, Italy
[3] Univ Verona, Pederzoli Hosp, Dept Med, Nephrol & Dialysis Unit, Verona, Italy
关键词
Physical exercise; Chronic kidney disease; Dialysis; Chronic kidney disease-mineral bone disorder; Anaemia; RENAL-DISEASE; HEMODIALYSIS-PATIENTS; LACTATE; MARKERS; IMPROVES;
D O I
10.1159/000540659
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Physical exercise (PE) can regulate inflammation, cardiovascular health, sarcopenia, anaemia, and bone health in the chronic kidney disease (CKD) population. Experimental and clinical studies both help us better understand the mechanisms that underlie the beneficial effects of the exercise, especially in renal anaemia and CKD-mineral bone disorders (CKD-MBDs). Here, we summarize this evidence, exploring the biological pathways involved, locally released substances, and crosstalk between tissues, but also the shortcomings of current knowledge. Summary: Anaemia: Both in healthy and CKD subjects, PE may mimic hypoxia, inhibiting PHDs; so hydroxylate HIF-alpha subunits may be translocated into the nucleus, resulting in dimerization of HIF-1 alpha and HIF-1 beta , recruitment of p300 and CBP, and ultimately, binding to HREs at target genes to cause activation. However, in CKD subjects acute PE causes higher levels of lactate, leading to iron restriction by upregulating hepatic hepcidin expression, while chronic PE allows an increased lactate clearance and HIF-alpha and VEGF alpha levels, stimulating both erythropoiesis and angiogenesis. CKD-MBD: PE may improve bone health decreasing bone resorption and increasing bone formation throughout at least three main pathways: (a) increasing osteoprotegerin and decreasing RANKL system; (b) decreasing cytokine levels; and (c) stimulating production of myokines and adipokines. Key Messages: Future research needs to be defined to develop evidence-based exercise guidance to provide optimal benefit for CKD using exercise interventions as adjuvant therapy for CKD-related complications such as anaemia and CKD-MBD. (c) 2024 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:812 / 820
页数:9
相关论文
共 50 条
  • [41] Mineral and bone disorder in chronic kidney disease: pioneering studies
    Floege, Juergen
    Drueke, Tilman B.
    KIDNEY INTERNATIONAL, 2020, 98 (04) : 807 - 811
  • [42] Pathophysiology of the chronic kidney disease - mineral bone disorder
    Hruska, Keith A.
    Seifert, Michael
    Sugatani, Toshifumi
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (04) : 303 - 309
  • [43] The use of bone turnover markers in chronic kidney disease-mineral and bone disorders
    Chiang, Cherie
    NEPHROLOGY, 2017, 22 : 11 - 13
  • [44] Role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder: A narrative review
    Shen, Yingjing
    MEDICINE, 2023, 102 (14) : E33477
  • [45] Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis
    Laster, Marciana
    Soohoo, Melissa
    Streja, Elani
    Elashoff, Robert
    Jernigan, Stephanie
    Langman, Craig B.
    Norris, Keith C.
    Salusky, Isidro B.
    Kalantar-Zadeh, Kamyar
    PEDIATRIC NEPHROLOGY, 2019, 34 (01) : 107 - 115
  • [46] Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), from Bench to Bedside
    Nitta, Kosaku
    Hanafusa, Norio
    Akiyama, Kenichi
    Kawaguchi, Yuki
    Tsuchiya, Ken
    KIDNEY AND DIALYSIS, 2023, 3 (01): : 46 - 55
  • [47] Pathophysiology of chronic kidney disease-mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis
    Salera, Davide
    Merkel, Nathalie
    Bellasi, Antonio
    de Borst, Martin H.
    CLINICAL KIDNEY JOURNAL, 2025, 18 : i3 - i14
  • [48] Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!
    Brandenburg, Vincent M.
    Verhulst, Anja
    Babler, Anne
    D'Haese, Patrick C.
    Evenepoel, Pieter
    Kaesler, Nadine
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (03) : 408 - 414
  • [49] The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor
    Ma, Xiaohong
    He, Liqun
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 54 - 60
  • [50] Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis
    Marciana Laster
    Melissa Soohoo
    Elani Streja
    Robert Elashoff
    Stephanie Jernigan
    Craig B. Langman
    Keith C. Norris
    Isidro B. Salusky
    Kamyar Kalantar-Zadeh
    Pediatric Nephrology, 2019, 34 : 107 - 115